H. Turtola

发表

Familial Hypercholesterolemia Patients Treated With Statins at No Increased Risk for Intracranial Vascular Lesions Despite Increased Cholesterol Burden and Extracranial Atherosclerosis

T. Autti, K. Lauerma, R. Raininko, 2005, Stroke.

Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns.

H. Gylling, T. Miettinen, A. Vuorio, 2002, The Journal of laboratory and clinical medicine.

Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences

P. Kovanen, H. Gylling, T. Miettinen, 2001, Annals of medicine.

Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation.

H. Gylling, T. Miettinen, K. Kontula, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Molecular genetics of familial hypercholesterolaemia: common and rare mutations of the low density lipoprotein receptor gene.

K. Kontula, U. Koivisto, H. Turtola, 1992, Annals of medicine.

Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.

M. Uusitupa, K. Pyörälä, T. Ebeling, 1992, Annals of medicine.

Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI

T. Autti, K. Lauerma, A. Vuorio, 2008, Vascular health and risk management.

Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland

J. Viikari, T. Ebeling, M. Savolainen, 1992, Journal of internal medicine.

Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.

M. Uusitupa, T. Ebeling, T. Miettinen, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia.

K. Kontula, A. Vuorio, H. Turtola, 1997, Arteriosclerosis, thrombosis, and vascular biology.

A novel point mutation (Pro84 ← Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemia

K. Kontula, A. Vuorio, H. Turtola, 1997, Clinical genetics.

Post mortem molecularly defined familial hypercholesterolemia and sudden cardiac death of young men.

A. Sajantila, K. Kontula, A. Vuorio, 1999, Forensic science international.

Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia

P. Saikku, K. Kontula, A. Vuorio, 1999, The Lancet.

Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low‐density‐lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment

K. Kontula, A. Vuorio, M. Tikkanen, 1995, Journal of internal medicine.

Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.

K Kontula, K. Kontula, P. Repo, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia

P. Kovanen, H. Gylling, T. Miettinen, 1989, Human Genetics.

The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.

K Kontula, A. Syvänen, R. Frants, 1992, The Journal of clinical investigation.

Deletions of the low density lipoprotein receptor gene underlying familial hypercholesterolaemia: screening by polymerase chain reaction using pooled DNA and blood samples.

L. Paulin, K. Kontula, A. Vuorio, 1997, Molecular and cellular probes.